Parallel Paths, Uneven Progress: Health Care Provider and Patient Perspectives on Anti‐Amyloid Therapies for Early AD

HCPs continue to build up the knowledge and competence needed to diagnose early AD and address the complexities of integrating anti-amyloid therapy in clinical practice. P/Cs are interested in new treatments but remain concerned about access, side effects, and stigma. These findings point to critical gaps in readiness and alignment that must be addressed to support the effective adoption of available therapies.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70861_108349
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Parallel Paths, Uneven Progress: Health Care Provider and Patient Perspectives on Anti‐Amyloid Therapies for Early AD

Brooks Kenny, Nathaniel A. Chin, Sydnee Robin Singer, Vandana V. Gupta et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Parallel Paths, Uneven Progress: Health Care Provider and Patient Perspectives on Anti‐Amyloid Therapies for Early AD

Brooks Kenny, Nathaniel A. Chin, Sydnee Robin Singer, Vandana V. Gupta, Carole Drexel, Scott Kaiser, Nancy Lynn, Monica Parsons, Dung Trinh
article en

Abstract

HCPs continue to build up the knowledge and competence needed to diagnose early AD and address the complexities of integrating anti-amyloid therapy in clinical practice. P/Cs are interested in new treatments but remain concerned about access, side effects, and stigma. These findings point to critical gaps in readiness and alignment that must be addressed to support the effective adoption of available therapies.

Alzheimer s & DementiaVol. 21(S7)
University of Wisconsin–Madison (US), Office of Patient Care Services (US), Pacific Heart Institute (US), Bright Cloud International (United States) (US), Texas Medical Association (US), Center For Social Innovation (US), California State University, Long Beach (US)
Openalex Percentile: Top 35%
Dementia and Cognitive Impairment Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.